scroll

PolyNovo (PNV)

ASX.PNV $1.31

20 MINUTE DELAYED

14 DAYS FREE ACCESS

Join Market Matters and get full access
to all our Opinion + Action

ASX.PNV $1.31

20 MINUTE DELAYED

TODAY

-3.69 %

1 YEAR RETURN

0.00%

VOLUME

2,256,250

DIV YIELD

PE RATIO

1,505.56

52 WEEK RANGE

0.84

2.92

ANALYSIS
OPINION
ACTION

ANALYSIS

Overview

SHARE PRICE ACTIVITY
Last (Price)	1.31
Change	-0.05 (-3.69)
Bid / Ask	1.31 - 1.32
Volume	2,256,250
Volume (3mths avg)	0
Turnover	3,077,135
Open	1.36
Day Range	1.31 - 1.42
VWAP	1.36
Prev Close	1.36
Last Trade	06.10 01/07 (AEST)

KEY INFORMATION
Sector	Healthcare
Shares Issued	573,905,411
NTA/Share	0.00
Last Dividend	0.00
Dividend Ex Date
Dividend Pay Date	15 MAR 2006

CURRENT ()
Revenue
EBITDA
Profit
Earnings Per Share (EPS)	0.00
Dividend Per Share (DPS)	0.00
Yield %	0.00
Market Cap	0.00
Price to Earnings Ratio (P/E)	1505.56

TARGET PRICE FORECAST

ESTIMATES ()
Revenue	0.00
EBITDA	0.00
Profit	0.00
Earnings Per Share (EPS)	0.00
Dividend Per Share (DPS)	0.00

BROKER CONSENSUS RECOMMENDATION

BUY

SELL

Target Price

0.00

Lt Growth Rate

0.00

Recommendation ()

0.00

OPINION

17/11/2021 09:32

PolyNovo Ltd (PNV) $1.54

Biotech / medical device business PNV has demonstrated the sectors volatility perfectly over the last 18-months i.e. firstly rallying by over 200% before plunging by over 60% back to where is started, a typical few years for many biotech names. The recent surprise resignation of the companies MD doesn’t bode well for the near term future news flow...

01/04/2021 09:12

PolyNovo Ltd (PNV) $2.71

PNV has fallen 30% in 2021 after missing revenue expectations in January, not a good look for growth socks.

ACTION

PNV

UPDATED 18/11/2021 09:15

MM is neutral PNV at best

Add To Hit List

Read the opinion

PNV

UPDATED 01/04/2021 08:56

MM is neutral PNV.

Add To Hit List

Business Summary

PolyNovo (PNV) is a biotechnology company. The Company has a portfolio of biodegradeable polymers that have potential for application across numerous medical fields.